cervical cancer
FDA Fully Approves Tivdak for Recurrent or Metastatic Cervical Cancer
The FDA granted traditional approval to Tivdak for recurrent or metastatic cervical cancer with disease ...
MAY 3, 2024
Keytruda With Chemoradiotherapy Approved for FIGO 2014 Stage III-IVA Cervical Cancer
The FDA approved Keytruda with chemoradiotherapy for patients with FIGO 2014 stage III to IVA cervical cancer.
JANUARY 19, 2024
Investigational Immunotherapy Looks Positive for HPV-Related Epithelial Cancers
In this phase 1 study, eight patients with metastatic HPV-16 cancers received a single infusion of KITE-439. In six ...
JULY 12, 2018
New Indications Granted for Keytruda
The FDA granted new indications to Keytruda for the primary mediastinal refractory or relapsed PMBCL and ...
JUNE 19, 2018
Load more